United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

vifor fresenius medical care renal pharma uk ltd - sucroferric oxyhydroxide - chewable tablet - 500mg

European Union - English - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - sucroferric oxyhydroxide - hyperphosphatemia; renal dialysis - drugs for treatment of hyperkalemia and hyperphosphatemia - velphoro is indicated for the control of serum phosphorus levels in adult chronic kidney disease (ckd) patients on haemodialysis (hd) or peritoneal dialysis (pd).velphoro is indicated for the control of serum phosphorus levels in paediatric patients 2 years of age and older with ckd stages 4-5 (defined by a glomerular filtration rate

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

vifor fresenius medical care renal pharma uk ltd - calcium acetate; magnesium carbonate heavy - oral tablet - 435mg ; 235mg

Israel - English - Ministry of Health

cts ltd - patiromer as sorbitex calcium - powder for suspension - patiromer as sorbitex calcium 16.8 g - patiromer calcium - veltassa is indicated for the treatment of hyperkalaemia in adults

Israel - English - Ministry of Health

cts ltd - patiromer as sorbitex calcium - powder for suspension - patiromer as sorbitex calcium 8.4 g - patiromer calcium - veltassa is indicated for the treatment of hyperkalaemia in adults

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

vifor pharma uk ltd - patiromer sorbitex calcium - powder - 16.8gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

vifor pharma uk ltd - patiromer sorbitex calcium - powder - 8.4gram

European Union - English - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - patiromer sorbitex calcium - hyperkalemia - drugs for treatment of hyperkalemia and hyperphosphatemia - veltassa is indicated for the treatment of hyperkalaemia in adults.

Ireland - English - HPRA (Health Products Regulatory Authority)

vifor fresenius medical care renal pharma france - calcifediol - prolonged-release capsule, soft - 30 microgram(s) - calcifediol; other anti-parathyroid agents

European Union - English - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - immunosuppressants - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).